Group Investor AB London S.E.

Manages and owns real estate properties

Designs and manufactures suction cups, vacuum pumps, system accessories and vacuum conveyors

Owns and manages real & movable properties

Provides biopharmaceuticals services

Provides investment services

Manufactures single-use surgical and wound care products

Owns and manages real estate

Manufactures absorbent airlaid nonwoven materials

Provides single-use surgical and wound care products

Manufacturers and sells wheelchairs through online

Develops, produces and markets reagents for biomedical research

Operates as a holding company whose subsidiaries manufactures products for wound care and surgical procedures

Operates as an investment and venture capital company

Operates as a real estate company that develops and manages clusters & commercial properties

Manufactures lifting equipment

IGC is a long-term investor with a top-down investment approach. They describe their investment attitude as patient and flexible. They are active investment partners seeking management teams operating in markets displaying sustainable growth characteristics. IGC commits themselves to board representation working closely for strategic decisions, financial and human resource allocations, potential acquisitions analyses and sources of additional capital. Their investee firms gain access to IGC's worldwide network of industry experts, advisors, and local knowledge over several geographic markets. IGC Europe invests primarily in expansion-stage firms in the technology and life sciences sectors in Northern Europe. They have an investment horizon from three to seven years. They typically invest between USD $3 million and $30 million. They acquire minority interest. IGC Asia targets expansion-stage firms in IT, software, semiconductors and Internet/media within Asia. Their investments range from USD $8 to $15 million over an investment period of three to six years. IGC US concentrates on investments in unlisted firms in healthcare and either listed or unlisted firms in IT sectors in North America. Generally, they invest in healthcare firms that have approved or marketed products. IT investments will typically be beyond the concept stage.